Works matching DE "NATALIZUMAB"

Results: 1783

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab.

Published in:

Drugs - Real World Outcomes, 2025, v. 12, n. 2, p. 301, doi. 10.1007/s40801-025-00495-w

By:

Blitz-Shabbir, Karen;
Banks, Aimee M.;
Garg, Hina;
Nelson, Flavia;
Shah, Suma;
Belviso, Nicholas;
Mendoza, Jason P.;
Avila, Robin L.;
Bian, Boyang;
Fong, Kinyee

Publication type:

Article

Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort.

Published in:

Drugs - Real World Outcomes, 2025, v. 12, n. 2, p. 165, doi. 10.1007/s40801-025-00486-x

By:

Guerra, Tommaso;
Caputo, Francesca;
Bianco, Antonella;
Paolicelli, Damiano;
Iaffaldano, Pietro

Publication type:

Article

Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 6, p. 1032, doi. 10.1002/psp4.70014

By:

van den Berg, Stefan P. H.;
Toorop, Alyssa A.;
Hooijberg, Femke;
Wolbink, Gertjan;
Voelkner, Nivea M. F.;
Gelissen, Liza M. Y.;
Killestein, Joep;
van Kempen, Zoé L. E.;
Dorlo, Thomas P. C.;
Rispens, Theo

Publication type:

Article

Diagnostic uncertainty in the era of biosimilar natalizumab—The case for harmonizing anti-JCV antibody testing.

Published in:

2025

By:

Ziemssen, Tjalf;
Centonze, Diego

Publication type:

Editorial

A comparison of JC virus assay performance provided with originator and biosimilar natalizumab.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 882, doi. 10.1177/13524585251346652

By:

Varley, James;
Beyrouti, Rahma;
Nicholas, Richard;
Dorsey, Rachel;
Brownlee, Wallace;
Paling, David;
Mathews, Joela;
Dobson, Ruth

Publication type:

Article

Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 877, doi. 10.1177/13524585251322683

By:

Vukusic, Sandra;
Hubben, Florian;
Gavoille, Antoine;
Malek, Yannis;
Casez, Olivier;
Kremer, Laurent;
Palpacuer, Thomas;
Marignier, Romain;
Durand-Dubief, Françoise;
Androdias-Condemine, Géraldine;
Pique, Julie;
Maillart, Elisabeth;
Vermersch, Patrick;
de Seze, Jérôme

Publication type:

Article

Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case report.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 886, doi. 10.1177/13524585241235539

By:

Kubicki, Konrad;
Stefoski, Dusan

Publication type:

Article

Acute Acalculous Cholecystitis in a Multiple Sclerosis Patient Treated with Natalizumab.

Published in:

2021

By:

Lambea-Gil, Alvaro;
Fumanal-Idocin, Luis;
Sebastián-Torres, Berta;
Saldaña-Inda, Ignacio;
Huici-Polo, Patxi;
Alarcia-José-Ramon- Ramon Ara-Callizo, Raquel

Publication type:

Case Study

The effect of crocin-selenium nanoparticles on the cognition and oxidative stress markers of multiple sclerosis patients: a randomized triple-blinded placebo-controlled clinical trial.

Published in:

BioMetals, 2024, v. 37, n. 2, p. 305, doi. 10.1007/s10534-023-00548-z

By:

Rezaeimanesh, Nasim;
Rafiee, Pegah;
Saeedi, Roghayyeh;
Khosravian, Pegah;
Sahraian, Mohammad Ali;
Eskandarieh, Sharareh;
Moghadasi, Abdorreza Naser;
Jahromi, Soodeh Razeghi

Publication type:

Article

Identification of the most cost-saving disease-modifying therapies and factors affecting the budget in the pharmacotherapy of multiple sclerosis: a systematic review.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 2, p. 247, doi. 10.1007/s00228-024-03783-6

By:

Jafari, Matin;
Sebty, Mehrshad;
Moradi, Shaghayegh;
Noqani, Hesam;
Esmaily, Hadi;
Mohammadnezhad, Ghader

Publication type:

Article

Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 4, p. 441, doi. 10.1007/s00228-011-1141-1

By:

Santo, Fabiola;
Maratea, Dario;
Fadda, Valeria;
Trippoli, Sabrina;
Messori, Andrea

Publication type:

Article

A novel comprehensive paradigm for the etiopathogenesis of multiple sclerosis: therapeutic approaches and future perspectives on its treatment.

Published in:

Amino Acids, 2019, v. 51, n. 5, p. 745, doi. 10.1007/s00726-019-02718-1

By:

Gasperoni, Francesco;
Turini, Paola;
Agostinelli, Enzo

Publication type:

Article

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait.

Published in:

Medical Principles & Practice, 2013, v. 22, n. 5, p. 495, doi. 10.1159/000351568

By:

Alroughani, R.;
Al Hashel, J.;
Thussu, A.;
Ahmed, S.F.

Publication type:

Article

Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.

Published in:

JAMA Network Open, 2024, v. 7, n. 4, p. e246345, doi. 10.1001/jamanetworkopen.2024.6345

By:

Carvajal, René;
Zabalza, Ana;
Carbonell-Mirabent, Pere;
Martínez-Gómez, Xavier;
Esperalba, Juliana;
Pappolla, Agustín;
Rando, Ariadna;
Cobo-Calvo, Alvaro;
Tur, Carmen;
Rodriguez, Marta;
Río, Jordi;
Comabella, Manuel;
Castilló, Joaquín;
Rodrigo-Pendás, José Ángel;
Braga, Nathane;
Mongay-Ochoa, Neus;
Guío-Sánchez, Claudia;
Vidal-Jordana, Ángela;
Arrambide, Georgina;
Rodríguez-Acevedo, Breogán

Publication type:

Article

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis.

Published in:

Journal of Rehabilitation & Assistive Technologies Engineering, 2022, v. 9, p. 1, doi. 10.1177/20556683211067362

By:

Keller, Jennifer L.;
Tian, Fan;
Fitzgerald, Kathryn C.;
Mische, Leah;
Ritter, Jesse;
Zackowski, Kathleen M.

Publication type:

Article

The societal impact of treatment with natalizumab of relapsing--remitting multiple sclerosis in Italian clinical practice: The Tysabri ® PharmacoEconomics (TyPE) Study.

Published in:

Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319852956

By:

Polistena, B.;
Spandonaro, F.;
Capra, R.;
Fantaccini, S.;
Santoni, L.;
Zimatore, G. B.;
Gasperini, C.

Publication type:

Article

Cognitive Impairment in Multiple Sclerosis.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 7, p. 871, doi. 10.3390/bioengineering10070871

By:

Maiese, Kenneth

Publication type:

Article

Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 7, p. 848, doi. 10.3390/bioengineering10070848

By:

Carlomagno, Vincenzo;
Mirabella, Massimiliano;
Lucchini, Matteo

Publication type:

Article

Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 1, p. 41, doi. 10.3390/bioengineering10010041

By:

Ziccardi, Stefano;
Pizzini, Francesca Benedetta;
Guandalini, Maddalena;
Tamanti, Agnese;
Cristofori, Cecilia;
Calabrese, Massimiliano

Publication type:

Article

Statement of Retraction: Elevated CSF concentration of CCL3 and CCL4 in relapsing remitting multiple sclerosis patients.

Published in:: 2023
Publication type:: Correction Notice

Anti-Mycobacterial Antibodies in Paired Cerebrospinal Fluid and Serum Samples from Japanese Patients with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.

Published in:

Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 522, doi. 10.3390/jcm7120522

By:

Yokoyama, Kazumasa;
Cossu, Davide;
Hoshino, Yasunobu;
Tomizawa, Yuji;
Momotani, Eiichi;
Hattori, Nobutaka

Publication type:

Article

Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, p. 1, doi. 10.1186/s40780-024-00332-2

By:

Fujimiya, Tatsuhiro;
Azuma, Kanako;
Togashi, Yuki;
Kuwata, Koji;
Unezaki, Sakae;
Takeuchi, Hironori

Publication type:

Article

Disease‐modifying therapies in multiple sclerosis: A focused review of rituximab.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 550, doi. 10.1111/bcpt.13932

By:

Alping, Peter

Publication type:

Article

Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 6, p. 492, doi. 10.1111/bcpt.13381

By:

Nørgaard, Thomas Lohne;
Andersen, Carl Uggerhøj;
Hilt, Claudia;
Andersen, Charlotte Uggerhøj

Publication type:

Article

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2024, v. 11, n. 8, p. 2008, doi. 10.1002/acn3.52118

By:

Iaffaldano, Pietro;
Lucisano, Giuseppe;
Guerra, Tommaso;
Paolicelli, Damiano;
Portaccio, Emilio;
Inglese, Matilde;
Foschi, Matteo;
Patti, Francesco;
Granella, Franco;
Romano, Silvia;
Cavalla, Paola;
De Luca, Giovanna;
Gallo, Paolo;
Bellantonio, Paolo;
Gallo, Antonio;
Montepietra, Sara;
Di Sapio, Alessia;
Vianello, Marika;
Quatrale, Rocco;
Spitaleri, Daniele

Publication type:

Article

A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2022, v. 9, n. 7, p. 977, doi. 10.1002/acn3.51574

By:

Fox, Robert J.;
Wiendl, Heinz;
Wolf, Christian;
De Stefano, Nicola;
Sellner, Johann;
Gryb, Viktoriia;
Rejdak, Konrad;
Bozhinov, Plamen Stoyanov;
Tomakh, Nataliya;
Skrypchenko, Iryna;
Muehler, Andreas R.

Publication type:

Article

Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial.

Published in:

Annals of Clinical & Translational Neurology, 2021, v. 8, n. 8, p. 1610, doi. 10.1002/acn3.51410

By:

Schultz, Timothy J.;
Thomas, Anne;
Georgiou, Paul;
Juaton, Mahasen S.;
Cusack, Lynette;
Simon, Lorraine;
Naidoo, Kerisha;
Webb, Kevin;
Karnon, Jonathan;
Ravindran, Janakan

Publication type:

Article

Improving risk‐stratification of natalizumab‐associated PML.

Published in:

Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 696, doi. 10.1002/acn3.51130

By:

Tugemann, Bastian;
Berger, Joseph R.

Publication type:

Article

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Published in:

Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 252, doi. 10.1002/acn3.700

By:

Vollmer, Brandi L.;
Nair, Kavita V.;
Sillau, Stefan;
Corboy, John R.;
Vollmer, Timothy;
Alvarez, Enrique

Publication type:

Article

TLR3 agonism re‐establishes CNS immune competence during α4‐integrin deficiency.

Published in:

Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1543, doi. 10.1002/acn3.664

By:

Hussain, Rehana Z.;
Cravens, Petra C.;
Doelger, Richard;
Dentel, Brianne;
Herndon, Emily;
Loof, Nicolas;
Tsai, Peter;
Okuda, Darin T.;
Racke, Michael K.;
Stüve, Olaf

Publication type:

Article

CD4 cell response to interval therapy with natalizumab.

Published in:

Annals of Clinical & Translational Neurology, 2015, v. 2, n. 5, p. 570, doi. 10.1002/acn3.190

By:

Berkovich, Regina;
Togasaki, Daniel M.;
Cen, Steven Y.;
Steinman, Lawrence

Publication type:

Article

Comparative efficacy of switching to natalizumab in active multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2015, v. 2, n. 4, p. 373, doi. 10.1002/acn3.180

By:

Spelman, Timothy;
Kalincik, Tomas;
Zhang, Annie;
Pellegrini, Fabio;
Wiendl, Heinz;
Kappos, Ludwig;
Tsvetkova, Larisa;
Belachew, Shibeshih;
Hyde, Robert;
Verheul, Freek;
Grand‐Maison, Francois;
Izquierdo, Guillermo;
Grammond, Pierre;
Duquette, Pierre;
Lugaresi, Alessandra;
Lechner‐Scott, Jeannette;
Oreja‐Guevara, Celia;
Hupperts, Raymond;
Petersen, Thor;
Barnett, Michael

Publication type:

Article

Natalizumab restores aberrant mi RNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.

Published in:

Annals of Clinical & Translational Neurology, 2015, v. 2, n. 1, p. 43, doi. 10.1002/acn3.152

By:

Ingwersen, Jens;
Menge, Til;
Wingerath, Britta;
Kaya, Derya;
Graf, Jonas;
Prozorovski, Tim;
Keller, Andreas;
Backes, Christina;
Beier, Markus;
Scheffler, Matthias;
Dehmel, Thomas;
Kieseier, Bernd C.;
Hartung, Hans‐Peter;
Küry, Patrick;
Aktas, Orhan

Publication type:

Article

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.

Published in:

Annals of Clinical & Translational Neurology, 2014, v. 1, n. 10, p. 755, doi. 10.1002/acn3.114

By:

Dong‐Si, Tuan;
Richman, Sandra;
Wattjes, Mike P.;
Wenten, Made;
Gheuens, Sarah;
Philip, Jeffrey;
Datta, Shoibal;
McIninch, James;
Bozic, Carmen;
Bloomgren, Gary;
Richert, Nancy

Publication type:

Article

Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma.

Published in:

Metabolites (2218-1989), 2024, v. 14, n. 1, p. 20, doi. 10.3390/metabo14010020

By:

Kimpel, Otilia;
Altieri, Barbara;
Dischinger, Ulrich;
Fuss, Carmina Teresa;
Kurlbaum, Max;
Fassnacht, Martin

Publication type:

Article

Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 3, p. 428, doi. 10.3390/metabo13030428

By:

Murgia, Federica;
Lorefice, Lorena;
Noto, Antonio;
Spada, Martina;
Frau, Jessica;
Fenu, Giuseppe;
Coghe, Giancarlo;
Gagliano, Antonella;
Atzori, Luigi;
Cocco, Eleonora

Publication type:

Article

Headache and Other Pain Syndromes in Multiple Sclerosis: A Narrative Review.

Published in:

Life (2075-1729), 2024, v. 14, n. 1, p. 87, doi. 10.3390/life14010087

By:

Sîrbu, Carmen Adella;
Rotaru, Andreea Ruxandra;
Antochi, Florina Anca;
Plesa, Andreea;
Manole, Aida Mihaela;
Roceanu, Adina Maria

Publication type:

Article

Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis.

Published in:

Life (2075-1729), 2023, v. 13, n. 11, p. 2132, doi. 10.3390/life13112132

By:

Maier, Smaranda;
Bajkó, Zoltán;
Roșescu, Ruxandra;
Bărcuțean, Laura;
Sărmășan, Emanuela;
Voidăzan, Septimiu;
Bălașa, Rodica

Publication type:

Article

Mycobacterium avium subsp. paratuberculosis Antigens Elicit a Strong IgG4 Response in Patients with Multiple Sclerosis and Exacerbate Experimental Autoimmune Encephalomyelitis.

Published in:

Life (2075-1729), 2023, v. 13, n. 7, p. 1437, doi. 10.3390/life13071437

By:

Cossu, Davide;
Tomizawa, Yuji;
Yokoyama, Kazumasa;
Sakanishi, Tamami;
Momotani, Eiichi;
Sechi, Leonardo A.;
Hattori, Nobutaka

Publication type:

Article

Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?

Published in:

Life (2075-1729), 2023, v. 13, n. 1, p. 226, doi. 10.3390/life13010226

By:

Di Stadio, Arianna;
Bernitsas, Evanthia;
La Mantia, Ignazio;
Brenner, Michael J.;
Ralli, Massimo;
Vaira, Luigi Angelo;
Colizza, Andrea;
Cavaliere, Carlo;
Laudani, Matteo;
Frohman, Teresa C.;
De Vincentiis, Marco;
Frohman, Elliot M.;
Altieri, Marta

Publication type:

Article

Nasal Microbiota and Neuroinflammation: Relationship between Nasal Flora and Multiple Sclerosis Onset/Progression.

Published in:

Life (2075-1729), 2022, v. 12, n. 12, p. 2043, doi. 10.3390/life12122043

By:

Gioacchini, Federico Maria;
Ferlito, Salvatore;
Ralli, Massimo;
Scarpa, Alfonso;
La Mantia, Ignazio;
Re, Massimo;
Romani, Luigina;
Di Stadio, Arianna

Publication type:

Article

Therapeutic Effects of Photobiomodulation Therapy on Multiple Sclerosis by Regulating the Inflammatory Process and Controlling Immune Cell Activity: A Novel Promising Treatment Target.

Published in:

Journal of Lasers in Medical Sciences, 2022, v. 13, p. 1, doi. 10.34172/jlms.2022.32

By:

Vafaei-Nezhad, Saeed;
Niknazar, Somayeh;
Payvandi, Ali Asghar;
Tehrani, Atefeh Shirazi;
Roozbahany, Ahmady;
Ahrabi, Behnaz;
Abbaszadeh, Hojjat Allah;
Darabi, Shahram

Publication type:

Article

Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.589146

By:

Sun, Yue;
Yang, Yanbo;
Wang, Zilan;
Jiang, Fan;
Chen, Zhouqing;
Wang, Zhong

Publication type:

Article

Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.556391

By:

Kim, Minju;
Lee, Soyoung;
Lim, Hyungjin;
Lee, Jihye;
Park, Ji-Young;
Kwon, Hyung-Jun;
Lee, In-Chul;
Ryu, Young-Bae;
Kim, Jeongtae;
Shin, Taekyun;
Ahn, Ginnae;
Rho, Mun-Chual;
Jung, Kyungsook

Publication type:

Article

Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00161

By:

de Oliveira, Larissa Ragozo Cardoso;
Mimura, Luiza Ayumi Nishiyama;
Fraga-Silva, Thais Fernanda de Campos;
Ishikawa, Larissa Lumi Watanabe;
Fernandes, Ana Angélica Henrique;
Zorzella-Pezavento, Sofia Fernanda Gonçalves;
Sartori, Alexandrina

Publication type:

Article

Differential Expression of HERV-W in Peripheral Blood in Multiple Sclerosis and Healthy Patients in Two Different Ethnic Groups.

Published in:

Frontiers in Pharmacology, 2020, v. 10, p. 1, doi. 10.3389/fphar.2019.01645

By:

Tarlinton, Rachael;
Wang, Belinda;
Morandi, Elena;
Gran, Bruno;
Khaiboullin, Timur;
Martynova, Ekatarina;
Rizvanov, Albert;
Khaiboullina, Svetlana

Publication type:

Article

Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis.

Published in:

Frontiers in Pharmacology, 2020, v. 10, p. 1, doi. 10.3389/fphar.2019.01491

By:

Hostenbach, Stéphanie;
D'Haeseleer, Miguel;
Kooijman, Ron;
De Keyser, Jacques

Publication type:

Article

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data.

Published in:

Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01239

By:

Rudroff, Thorsten

Publication type:

Article

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.

Published in:

Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.901233

By:

Wang, Fa-Da;
Zhou, Jing;
Li, Lan-Qing;
Wang, Meng-Lan;
Tao, Ya-Cao;
Wang, Yong-Hong;
Zhang, Dong-Mei;
Chen, En-Qiang

Publication type:

Article

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01916

By:

Buscarinu, Maria Chiara;
Fornasiero, Arianna;
Romano, Silvia;
Ferraldeschi, Michela;
Mechelli, Rosella;
Reniè, Roberta;
Morena, Emanuele;
Romano, Carmela;
Pellicciari, Giulia;
Landi, Anna Chiara;
Salvetti, Marco;
Ristori, Giovanni

Publication type:

Article